Gemar, Ruben N.
HRN: 01-54-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/19/2023
01/26/2023
IV
1.5gram
Q6hrs As IV Infusion
Infected Wound At Left Hand
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes